Tenaya Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| COLUMN GROUP III, LP | — | Purchase | 9,615,384 | $2.60 | $24,999,998 | 9,615,384 | Nov 21, 2022 |
| Srivastava Deepak | — | Purchase | 230,769 | $2.60 | $599,999 | 372,435 | Nov 21, 2022 |
| Casdin Capital, LLC | — | Purchase | 2,492,042 | $2.60 | $6,479,309 | 6,078,860 | Nov 17, 2022 |
| Hoey Timothy | Chief Scientific Officer | Sale | 1,353 | $10.13 | $13,706 | 198,646 | Apr 26, 2022 |
| Kang JeenJoo | — | C | 12,500 | — | — | 25,000 | Aug 3, 2021 |
| GOEDDEL DAVID V | — | C | 4,389,282 | — | — | 4,414,720 | Aug 3, 2021 |
| Casdin Eli | — | C | 2,374,849 | — | — | 2,374,849 | Aug 3, 2021 |
| Casdin Private Growth Equity Fund, L.P. | — | C | 361,969 | — | — | 361,969 | Aug 3, 2021 |
| COLUMN GROUP III, LP | — | C | 4,956,842 | — | — | 4,985,570 | Aug 3, 2021 |